The growth of the genomics market is driven by the rising prevalence of genetic disorders and cancer, along with increasing awareness of early disease detection through genetic testing.WILMINGTON ...

Scientists at the University of Virginia School of Medicine are chasing a new way to slow glioblastoma, the deadliest brain ...

Prenatal imaging identified situs inversus totalis, and whole exome sequencing found DNAH11 variants. The case highlights how ...

Comprehensive residue-level mapping of amyloid-beta recognition reveals how sequence variants, post-translational ...

Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 5% year on year ...

Spatial omics is a new generation of technologies that allow scientists to study cells in their original location within ...

Young Arthur is just 17 months old and is facing a lengthy stay at Great Ormond Street hospital ...

Twist Bioscience Corporation (NASDAQ:TWST) Q1 2026 Earnings Call Transcript February 2, 2026 Twist Bioscience Corporation ...

With Q3 behind us, let’s have a look at Illumina (NASDAQ:ILMN) and its peers. The life sciences tools and services sector supports biotech and pharmaceutical R&D and commercialization by providing lab ...

Twist Bioscience Corporation Q1 2026 revenue rose 17% and guidance increased. Click for this updated look at TWST stock ...

For instance, some products that are used to perform various in vitro diagnostic tests using various technologies involve real time PCR detection systems, immunoassay systems, and others. In vitro ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $128.8, a high estimate of $170.00, and a low estimate of $100.00. This current ...